From the most effective new cardiac treatments to staying ahead of the latest scientific advances, innovation is at the heart of MedStar Heart Institute. The Heart Institute is a pipeline to the most important new research and developments for its physicians, which translates into state-of-the-art care for patients.
Through our Cardiovascular Research Institute, we bring the benefits of pioneering research and clinical trials to patients from throughout the region. At any time, we are involved in 30 to 50 investigational trials for the treatment of heart disease, and our cardiologists and cardiac surgeons publish their findings widely.
Here are just a few of the highlights from our previous research and clinical trials:
- We were the first in the region to institute the now widely-used TAVR procedure (transcatheter aortic valve replacement), serving as early pioneers in the clinical trial, examining a minimally invasive procedure to treat patients with aortic stenosis who are too ill to undergo traditional surgery. We added more than 200 patients into the national clinical trial, and we are considered one of the international leaders in this area, and we continue to explore the latest technology with various new heart valves. TAVR is offered in only a few places in our region.
- Our Advanced Heart Failure Team pioneered the testing and development of ventricular assist devices (VADs) since 1988. Today, VADs are routinely used as bridges to transplantation and, for some patients, a long-term solution for advanced heart failure.
- We are assessing a treatment for coronary arteries that uses completely biodegradable stents that dissolve once treatment is complete.
- We are leading studies into novel medical therapies following heart attacks or for the treatment of coronary artery disease to improve heart function and decrease the chance of patients having future heart attacks.
- We are assessing the MitraClip—a catheter-based therapy—for percutaneous repair of mitral valve